Braingaze is driving forward a pipeline of clinical applications of its unique IP covering various therapeutic areas

The Braingaze pipeline addresses some of the most prevalent neurodevelopment and neurocognitive conditions, as well as the critical need to early detect Mild Cognitive Impairment early on. Due to the digital nature of our solutions, our pipeline provides an accelerated assessment process across range of conditions.

Braingaze is driving forward a pipeline of clinical applications of its unique IP covering various therapeutic areas

The Braingaze pipeline addresses some of the most prevalent neurodevelopment and neurocognitive conditions, as well as the critical need to early detect Mild Cognitive Impairment early on. Due to the digital nature of our solutions, our pipeline provides an accelerated assessment process across range of conditions.

Science based

Braingaze solutions are the result of over 5 years of research & development of science-based tools. The solutions have been developed and validated in collaboration with leading clinicians.

The people behind Braingaze

Prof. Dr. Hans Supèr

Neurobiologist

Co-founder and CTO of Braingaze

Dr. José Alda

ADHD Lead

St Joan de Deu Specialized Pediatric Hospital

Dr. Jordi Royo i Isach

Clinical Psychologist

Amalgama7 Clinical Director

Clinical validation in collaboration with leaders in the therapeutic fields of interest

Right from the initial Proof of Concept stage, our clinical validation work is done in close collaboration with recognized leaders in the fields we touch upon. Any validation study we do is subsequently documented and presented for peer review in highly selective scientific journals. Our studies compare our solutions fairly with alternatives and aim for objectively measureable impact - not self-reported improvements which are highly susceptible to study participant bias.

Clinical validation in collaboration with leaders in the therapeutic fields of interest

Right from the initial Proof of Concept stage, our clinical validation work is done in close collaboration with recognized leaders in the fields we touch upon. Any validation study we do is subsequently documented and presented for peer review in highly selective scientific journals. Our studies compare our solutions fairly with alternatives and aim for objectively measureable impact - not self-reported improvements which are highly susceptible to study participant bias.

Mental Health & Psychiatry

Neurodevelopmental conditions, such as ADHD and ASC or autism are associated with differences in cognitive processing. A key structure in cognitive processing is the brainstem, which is located deep in our brain. The brainstem controls a range of tasks, including attention and memory but also directs eye movements. Monitoring carefully a specific eye movement (cognitive vergence) during a particular task allows detecting neurodevelopmental conditions cognitive disorders in an objective manner and with high precision.

Mental Health & Psychiatry

Neurodevelopmental conditions, such as ADHD and ASC or autism are associated with differences in cognitive processing. A key structure in cognitive processing is the brainstem, which is located deep in our brain. The brainstem controls a range of tasks, including attention and memory but also directs eye movements. Monitoring carefully a specific eye movement (cognitive vergence) during a particular task allows detecting neurodevelopmental conditions cognitive disorders in an objective manner and with high precision.

Neurology

Alzheimer ́s Disease is a neurodegenerative illness, manifested by progressive cognitive impairment. It results in severe synaptic and neuronal loss. Recently, studies show that the brainstem nucleus locus coeruleus is the first region to develop pathological precursors and is a critical step in the pathogenesis of Alzheimer ́s Disease. Cognitive vergence and also pupil diameter are closely linked to the functioning of brainstem nuclei including the locus coeruleus. Our and other studies demonstrate that altered responses in these eye metrics reflect dysfunctional functioning of the brainstem.


Neurology

Alzheimer ́s Disease is a neurodegenerative illness, manifested by progressive cognitive impairment. It results in severe synaptic and neuronal loss. Recently, studies show that the brainstem nucleus locus coeruleus is the first region to develop pathological precursors and is a critical step in the pathogenesis of Alzheimer ́s Disease. Cognitive vergence and also pupil diameter are closely linked to the functioning of brainstem nuclei including the locus coeruleus. Our and other studies demonstrate that altered responses in these eye metrics reflect dysfunctional functioning of the brainstem.


Solutions Pipeline

Solutions Pipeline

Scientific papers

Scientific papers